Search results for "Vaccines"
COVID-19 Vaccine Forum: What Physicians Need to Know
The Oct. 16 forum hosted by ACP and Annals of Internal Medicine will feature a panel of experts including Anthony S. Fauci, MD, MACP.
https://immattersacp.org/weekly/archives/2020/10/06/2.htm
6 Oct 2020
Tirzepatide for weight management, at-home STI tests
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/01/tirzepatide-for-weight-management-at-home-sti-tests.htm
1 Jan 2024
Fourth vaccine dose 62% effective against severe COVID-19 in month after receipt
Retrospective data from Israel showed that in people ages 60 years and older, an additional booster dose of the Pfizer-BioNTech COVID-19 vaccine was 55% effective against symptomatic disease and 68% effective against hospitalization.
https://immattersacp.org/weekly/archives/2022/04/19/4.htm
19 Apr 2022
Q&A with ACP's President on COVID-19 vaccines
George M. Abraham, MD, MPH, MACP, ACP's President, recently discussed the difference between third shots and boosters and other complexities of vaccination, as well as offered advice to internists on getting more patients vaccinated.
https://immattersacp.org/weekly/archives/2021/11/23/1.htm
23 Nov 2021
Q&A: Conquering the ABCs of coding and documentation
Early career physicians may feel overwhelmed by having to document the care they provide, but an expert explains why it's not as confusing as it used to be.
https://immattersacp.org/archives/2024/02/qanda-conquering-the-abcs-of-coding-and-documentation.htm
1 Feb 2024
MKSAP Quiz: Evaluation for multiple myeloma
A 64-year-old man is evaluated following a recent diagnosis of multiple myeloma. Chemotherapy is planned to begin in 14 days. Which prophylactic therapy is indicated today?
https://immattersacp.org/weekly/archives/2023/12/05/3.htm
5 Dec 2023
HPV vaccine impacts disease, screening
While HPV immunization is recommended during adolescence, internists practicing in the postvaccine era have their own host of considerations: namely, screening for cervical cancer and providing catch-up vaccination.
https://immattersacp.org/archives/2017/02/hpv.htm
1 Feb 2017
New research adds to data on symptoms after COVID-19, vaccines' effects
Several COVID-19 studies looked at persistent symptoms, while new vaccine research found limited antibody responses in some patients and advised on tests for clotting complications. Other studies quantified the target population for tocilizumab treatment and gender differences in infections.
https://immattersacp.org/weekly/archives/2021/05/25/1.htm
25 May 2021
Comprehensive study finds vaccines remarkably safe
The most common safety issue that resulted in label changes for vaccines was a restriction on the population to be vaccinated, such as pregnant or immunocompromised patients.
https://immattersacp.org/weekly/archives/2020/07/28/4.htm
28 Jul 2020
New herpes zoster vaccine brings familiar challenges
A new vaccine should be considered the preferred option for prevention of shingles in adults and should be given in place of the existing one, but it brings with it familiar considerations: efficacy, insurance, and patient communication.
https://immattersacp.org/archives/2018/02/new-herpes-zoster-vaccine-brings-familiar-challenges.htm
1 Feb 2018